BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1002 related articles for article (PubMed ID: 19538318)

  • 1. Mechanisms of diarrhea in inflammatory bowel diseases.
    Binder HJ
    Ann N Y Acad Sci; 2009 May; 1165():285-93. PubMed ID: 19538318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial tight junctions in intestinal inflammation.
    Schulzke JD; Ploeger S; Amasheh M; Fromm A; Zeissig S; Troeger H; Richter J; Bojarski C; Schumann M; Fromm M
    Ann N Y Acad Sci; 2009 May; 1165():294-300. PubMed ID: 19538319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of disturbed electrolyte transport in intestinal inflammation.
    Seidler U; Lenzen H; Cinar A; Tessema T; Bleich A; Riederer B
    Ann N Y Acad Sci; 2006 Aug; 1072():262-75. PubMed ID: 17057206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications.
    Mankertz J; Schulzke JD
    Curr Opin Gastroenterol; 2007 Jul; 23(4):379-83. PubMed ID: 17545772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dislocation of tight junction proteins without F-actin disruption in inactive Crohn's disease.
    Oshitani N; Watanabe K; Nakamura S; Fujiwara Y; Higuchi K; Arakawa T
    Int J Mol Med; 2005 Mar; 15(3):407-10. PubMed ID: 15702229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic diarrhea with special reference to ulcerative colitis and Crohn disease].
    Lammer F
    Schweiz Rundsch Med Prax; 1993 Apr; 82(16):481-6. PubMed ID: 8488352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal tissue kallikrein-kallistatin profile in inflammatory bowel disease.
    Stadnicki A; Mazurek U; Plewka D; Wilczok T
    Int Immunopharmacol; 2003 Jul; 3(7):939-44. PubMed ID: 12810351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.
    Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA
    Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of a rapid fecal latex agglutination test detecting the neutrophil protein, lactoferrin, for diagnosing inflammatory causes of chronic diarrhea.
    Fine KD; Ogunji F; George J; Niehaus MD; Guerrant RL
    Am J Gastroenterol; 1998 Aug; 93(8):1300-5. PubMed ID: 9707055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defense mechanisms in inflammatory bowel disease.
    Hyphantis TN; Triantafillidis JK; Pappa S; Mantas C; Kaltsouda A; Cherakakis P; Alamanos Y; Manousos ON; Mavreas VG
    J Gastroenterol; 2005 Jan; 40(1):24-30. PubMed ID: 15692786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracolonic manifestations of inflammatory bowel disease.
    Kozarek RA
    Am Fam Physician; 1987 Feb; 35(2):205-11. PubMed ID: 3812173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease).
    Ruther U; Nunnensiek C; Muller HA; Bader H; May U; Jipp P
    Hepatogastroenterology; 1998; 45(21):691-9. PubMed ID: 9684118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R
    Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in yeast intolerance between patients with Crohn's disease and ulcerative colitis.
    Brunner B; Scheurer U; Seibold F
    Dis Colon Rectum; 2007 Jan; 50(1):83-8. PubMed ID: 17096175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular changes in ulcerative colitis and Leśniowski-Crohn's disease.
    Zurawski J; Woźniak A; Salwa-Zurawska W; Kaczmarek E; Majewski P
    Pol J Pathol; 2007; 58(1):13-21. PubMed ID: 17585538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Extraintestinal manifestations of inflammatory bowel disease].
    Rogler G; Schölmerich J
    Med Klin (Munich); 2004 Mar; 99(3):123-30. PubMed ID: 15024484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease.
    Vestergaard P
    Minerva Med; 2004 Dec; 95(6):469-80. PubMed ID: 15785432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetics and immunopathogenesis of inflammatory bowel disease.
    Cho JH
    Nat Rev Immunol; 2008 Jun; 8(6):458-66. PubMed ID: 18500230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diarrhea in intestinal inflammatory diseases].
    Guédon C; Colin R
    Rev Prat; 1989 Dec; 39(29):2603-6. PubMed ID: 2602892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paediatric inflammatory bowel disease in New Zealand.
    Yap J; Wesley A; Mouat S; Chin S
    N Z Med J; 2008 Oct; 121(1283):19-34. PubMed ID: 18841182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.